The Hypercalcaemic Syndrome in Rats Bearing the Walker Carcinosarcoma 256
Overview
Authors
Affiliations
The strain of Walker carcinosarcoma 256 described induces hypercalcaemia, hyperphosphataemia and hyperuraemia in tumour bearing rats. Changes in calcium and phosphorus excretion are observed as well as accompanying calcification of soft tissue organs and loss of bone calcium. These changes in calcium metabolism disappear after removal of the tumour, so that long-range action of the tumour can be stated. The results are discussed in comparison with three other animal models of tumour dependent hypercalcaemia.
Waki Y, Miyamoto K, Kasugai S, Ohya K Jpn J Cancer Res. 1995; 86(5):470-6.
PMID: 7540609 PMC: 5920849. DOI: 10.1111/j.1349-7006.1995.tb03080.x.
Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma.
Seyberth H, Bonsch G, Muller H, Minne H, Erlenmaier T, Strein K Br J Cancer. 1980; 42(3):455-61.
PMID: 7426347 PMC: 2010425. DOI: 10.1038/bjc.1980.258.
Partial characterization of a bone-derived chemotactic factor for tumor cells.
Orr F, Varani J, Gondek M, Ward P, Mundy G Am J Pathol. 1980; 99(1):43-52.
PMID: 7361862 PMC: 1903471.
Rodan S, Insogna K, Vignery A, Stewart A, Broadus A, Dsouza S J Clin Invest. 1983; 72(4):1511-5.
PMID: 6685137 PMC: 370436. DOI: 10.1172/JCI111108.
Rix E, Raue F, Deutschle I, Ziegler R Histochemistry. 1984; 80(5):503-8.
PMID: 6548209 DOI: 10.1007/BF00495442.